Federal prisons used just a fraction of the antiviral drugs they were allocated to keep incarcerated people from getting seriously ill or dying of COVID-19, according to new internal records from the Bureau of Prisons.
Prison officials have only prescribed 363 doses of antivirals since the first such drug proven to work, Gilead’s Remdesivir, was authorized in May 2020. At least 55,000 of the roughly 137,000 people held in federal prisons have contracted COVID-19; roughly 300 have died.
Experts have lamented that the number of therapies allocated to federal prisons has been wholly insufficient to blunt the COVID-19 surge in those facilities. But the new documents reveal that the number of incarcerated people actually receiving antiviral drugs is even smaller than the allocation numbers suggest.
Source: STAT News
Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021
Outpatient Visits for COVID-19 and Associated Antibiotic Prescriptions Among Medicare Beneficiaries Aged 65 Years or Older, by Setting, US, April 2020 to April 2021. The volume of COVID-19 visits differed by setting: emergency department, 525 608 (45.8% of all visits); office, 295 983 (25.3%); telehealth, 260 261 (22.3%); and urgent care, 77 268 (6.6%).
Source: Journal of American Medical Association Network